
Patients with mild to moderate Alzheimer’s disease currently have no treatment options to slow brain cell deterioration. Researchers are studying an investigational drug that proposes to do just that.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/pxFHo2myE9o/140820105846.htm